Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

During the Trading Day
82.78 -1.59 / -1.88%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
82.78 0.00 / 0.00%
 
Volume: 41.0K

Today’s Trading

Previous close84.37
Today’s open85.13
Day’s range82.17 - 85.88
Volume1,541,202
Average volume (3 months)1,667,317
Market cap$9.9B
Dividend yield--
Data as of 4:01pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-582.35%
Earnings growth (this year)+48.21%
Earnings growth (next 5 years)+15.81%
Revenue growth (last year)+15.24%
P/E ratioNM
Price/Sales2.30
Price/Book1.97

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-3.46-2.06%
ALKSAlkermes Plc-0.20-0.32%
RDYDr.Reddy's Laborator...-0.91-1.41%
MDVNMedivation Inc-1.80-2.01%
Data as of 4:02pm ET, 09/03/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$1.82
Annual revenue (last year)$2.5B
Annual profit (last year)-$319.3M
Net profit margin-12.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers